These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 15563635
1. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. Am J Respir Crit Care Med; 2005 Mar 01; 171(5):494-9. PubMed ID: 15563635 [Abstract] [Full Text] [Related]
2. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H. J Cardiovasc Pharmacol; 2007 Feb 01; 49(2):85-9. PubMed ID: 17312448 [Abstract] [Full Text] [Related]
3. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, Oka M. Am J Physiol Lung Cell Mol Physiol; 2004 Oct 01; 287(4):L665-72. PubMed ID: 12959926 [Abstract] [Full Text] [Related]
4. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat. Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Am J Physiol Heart Circ Physiol; 2010 Jul 01; 299(1):H184-92. PubMed ID: 20435851 [Abstract] [Full Text] [Related]
5. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Oka M, Homma N, Taraseviciene-Stewart L, Morris KG, Kraskauskas D, Burns N, Voelkel NF, McMurtry IF. Circ Res; 2007 Mar 30; 100(6):923-9. PubMed ID: 17332430 [Abstract] [Full Text] [Related]
14. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency. Gupta N, Rashid J, Nozik-Grayck E, McMurtry IF, Stenmark KR, Ahsan F. Mol Pharm; 2017 Mar 06; 14(3):830-841. PubMed ID: 28165252 [Abstract] [Full Text] [Related]
17. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. Am J Physiol Lung Cell Mol Physiol; 2004 Oct 06; 287(4):L656-64. PubMed ID: 14977625 [Abstract] [Full Text] [Related]
19. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension. Xing XQ, Gan Y, Wu SJ, Chen P, Zhou R, Xiang XD. Drug News Perspect; 2006 Nov 06; 19(9):517-22. PubMed ID: 17220956 [Abstract] [Full Text] [Related]
20. Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat. Badejo AM, Dhaliwal JS, Casey DB, Gallen TB, Greco AJ, Kadowitz PJ. Am J Physiol Lung Cell Mol Physiol; 2008 Nov 06; 295(5):L828-36. PubMed ID: 18689606 [Abstract] [Full Text] [Related] Page: [Next] [New Search]